Member Matthew Gardella was a panelist on Scrip's M&A Podcast, where he discussed the state of biopharma M&A, including the record pace of activity in 2023 and the implications of mega deals like the Pfizer/Seagen merger.

 

Source

Scrip M&A Podcast